@article{1bb336f7231446d1aa2798b1b68139b4,
title = "Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials",
abstract = "The risk of cancer from antihypertensive drugs has been much debated, with a recent analysis showing increased risk with angiotensin-receptor blockers (ARBs). We assessed the association between antihypertensive drugs and cancer risk in a comprehensive analysis of data from randomised clinical trials.",
keywords = "Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Antihypertensive Agents, Calcium Channel Blockers, Drug Therapy, Combination, Humans, Hypertension, Neoplasms, Randomized Controlled Trials as Topic, Risk",
author = "Sripal Bangalore and Sunil Kumar and Kjeldsen, {Sverre E} and Harikrishna Makani and Ehud Grossman and J{\o}rn Wetterslev and Gupta, {Ajay K} and Sever, {Peter S} and Christian Gluud and Messerli, {Franz H}",
note = "Copyright {\^A}{\textcopyright} 2011 Elsevier Ltd. All rights reserved.",
year = "2011",
doi = "10.1016/S1470-2045(10)70260-6",
language = "English",
volume = "12",
pages = "65--82",
journal = "Lancet Oncology",
issn = "1470-2045",
publisher = "Elsevier Limited",
number = "1",
}